Stockholders' Equity (Details)	6 Months Ended
	Jun. 30, 2020 USD ($) $ / shares shares
Equity [Abstract]
Number of Options, Outstanding, Beginning balance | shares	1,290,000
Number of Options Outstanding, Granted | shares	125,000
Number of Options, Outstanding, Ending balance | shares	1,415,000
Number of Options, Exercisable | shares	1,200,000
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 0.99
Weighted Average Exercise Price, Granted | $ / shares	1.00
Weighted Average Exercise Price, Ending balance | $ / shares	0.99
Weighted Average Exercise Price, Exercisable | $ / shares	$ 0.99
Weighted Average Remaining Contractual Term (Years), Outstanding, Beginning balance	5 years 8 months 26 days
Weighted Average Remaining Contractual Term (Years), Outstanding, Ending balance	5 years 7 months 13 days
Weighted Average Remaining Contractual Term (Years), Exercisable	5 years 2 months 27 days
Aggregate Intrinsic Value, Beginning balance | $
Aggregate Intrinsic Value, Granted | $
Aggregate Intrinsic Value, Ending balance | $
Aggregate Intrinsic Value, Exercisable | $
Number of shares, Balance Non-vested at December 31, 2019 | shares	125,000
Number of shares, granted non-vested | shares	125,000
Number of shares, Vested during the year | shares	(35,000)
Number of shares, Balance Non-vested at march 31, 2020 | shares	215,000
, Balance Non-vested at December 31, 2018 | $ / shares	$ 1.00
Weighted Average Exercise Price, granted non-vested | $ / shares	1.00
Weighted Average Exercise Price, Vested during the year | $ / shares	1.00
Weighted Average Exercise Price, Balance Non-vested at June 30, 2019 | $ / shares	$ 1.00
Weighted Average Remaining Contractual Term (Years), Balance Non-vested at march 31, 2020	7 years 9 months 7 days
Aggregate Intrinsic Value, Balance Non-vested at December 31, 2019 | $
Aggregate Intrinsic Value, Balance vested | $
Aggregate Intrinsic Value, Balance Non-vested at march 31, 2020 | $